Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

Ovarian cancer is the most lethal gynaecologic malignancy. Although there are various subtypes of ovarian cancer, high-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer deaths. Chemoresistance is the primary reason for the unfavourable prognosis of HGSOC. Kallistatin (KAL), also...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Ovarian Res
Auteurs principaux: Wu, Huan, Li, Rongrong, Zhang, Zhiwei, Jiang, Huiyang, Ma, Hanlin, Yuan, Cunzhong, Sun, Chenggong, Li, Yingwei, Kong, Beihua
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935502/
https://ncbi.nlm.nih.gov/pubmed/31884974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-019-0601-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires